BALAMINES Balaji Amines Q4 FY25 results (Jan–Mar 2025) and concall
Balaji Amines reported a strong sequential recovery in Q4 FY25, with consolidated revenue, EBITDA, and PAT showing double-digit QoQ growth. However, the full year FY25 performance saw a decline in revenue and profitability compared to FY24, impacted by input costs and pricing pressures. The company is actively pursuing significant capacity expansions and new product commercializations across standalone and subsidiary operations, with several projects slated for commissioning in FY26 and FY27, aiming for future growth despite current market volatility.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 |
|---|---|---|---|
| Revenue | 347 | 313 | 353 |
| EBITDA | 61 | 46 | 60 |
| Net profit | 41 | 31 | 40 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
